Specialty Account Manager, Auvelity (Atlanta South)

Specialty Account Manager, Auvelity (Nashville East)

Specialist/Sr. Specialist, QA Compliance

Manager, Sales Operations

TMF Specialist 

Manager/Senior Manager, Compliance

Manager/Senior Manager, Compliance (Midwest or West Region)

Director, Government and Regional Accounts (Mid-West and North East)

Director, Government and Regional Accounts (Mid-Atlantic & South East)

Product Manager/Senior Product Manager, HCP Marketing

Director, Intellectual Property

Director, Government and Regional Accounts (West)

Associate Director, Commercial Data Operations

Manager, Medical Information

Associate Director/Director, Biostatistics (Medical and Real-World Evidence)  

Manager, Commercial Sales Operations

Clinical Trial Manager

Associate Director, Clinical Operations

Submit Your Resume for Future Opportunities - Corporate Roles

Manager/Senior Manager, Quality 

Staff Accountant

Director, Clinical Operations

Submit Your Resume for Future Opportunities - Sales Roles

Senior Clinical Research Associate - FL

Senior Manager/Associate Director, Analytical Development

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ascidian Therapeutics

Ascribe Bioscience

Axsome Therapeutics is developing therapies that target the central nervous system (CNS) to help patients with depression, migraines, narcolepsy, fibromyalgia and smoking addiction. Axsome is designing therapeutic options with novel mechanisms of action to transform the current approach to treat CNS disorders. This approach involves internally-derived candidates and in-licensed candidates with development and commercialization. Axsome’s pipeline is already diversified with 4 lead compounds in Phase 1,2 & 3 clinical trials targeting conditions that currently have limited treatment options. One compound, AXS-05, is an oral NMDA receptor antagonist to treat depression and Alzheimer’s disease agitation. 

<p>Axsome Therapeutics is developing therapies that target the central nervous system (CNS) to help patients with depression, migraines, narcolepsy, fibromyalgia and smoking addiction. Axsome is designing therapeutic options with novel mechanisms of action to transform the current approach to treat CNS disorders. This approach involves internally-derived candidates and in-licensed candidates with development and commercialization. Axsome’s pipeline is already diversified with 4 lead compounds in Phase 1,2 &amp; 3 clinical trials targeting conditions that currently have limited treatment options. One compound, AXS-05, is an oral NMDA receptor antagonist to treat depression and Alzheimer’s disease agitation. </p>


Axsome Therapeutics

Find a biotech startup job.